WeedLife News Network

The origin story for Mothers Mary, an online community of mothers who consume cannabis, begins on Facebook.

CBD capsules are often marketed as being a modern and simplistic alternative to traditional CBD oil tinctures. CBD capsules remove many of the factors that can put people off trying CBD supplements. As a result, they have quickly become one of the fastest-growing niches within the CBD industry.

There are many reasons why people are increasingly looking for products like CBD capsules. There have been a number of studies focusing on how regular use of CBD can help to improve both general health and even manage specific health issues.

With an ever growing number of people turning to CBD supplements – including capsules – the industry has responded. Now, one can find a variety of CBD capsule options available across a range of online and retail markets.

Knowing where to find the best CBD capsules and soft gels can feel a little daunting at first. We have put together a guide to some of the best CBD capsules on the market to help you discover the benefits of CBD supplements.

#1 PureKana – Best for targeted effects 

CBD capsules are often marketed as being a modern and simplistic alternative to traditional CBD oil tinctures. CBD capsules remove many of the factors that can put people off trying CBD supplements. As a result, they have quickly become one of the fastest-growing niches within the CBD industry.

There are many reasons why people are increasingly looking for products like CBD capsules. There have been a number of studies focusing on how regular use of CBD can help to improve both general health and even manage specific health issues.

With an ever growing number of people turning to CBD supplements – including capsules – the industry has responded. Now, one can find a variety of CBD capsule options available across a range of online and retail markets.

Knowing where to find the best CBD capsules and soft gels can feel a little daunting at first. We have put together a guide to some of the best CBD capsules on the market to help you discover the benefits of CBD supplements.

#1 PureKana – Best for targeted effects 

Hopefully, in time, these cities will reevaluate the deleterious effects these ordinances have on sales taxes and consumer choice.

Arizonans knew zoning issues could cause headaches for dispensary owners. However, what was unanticipated are the new bans by some of the Arizona cities for recreational marijuana establishments.

Shortly after the passage of Proposition 207, otherwise known as the Smart and Safe Arizona Act (the “Act”), several Arizona cities moved to ban recreational marijuana sales, unless the dispensary is a “dual licensee”. A dual licensee means an establishment that is licensed both as a medical marijuana establishment and an adult use (or recreational) establishment.

With the cannabis world trending in the direction of CBD, strains with high CBD content are taking center stage.

The result to be expected from using cannabis depends on cannabis strains and their cannabinoid profile. Cannabis has two major strains namely Sativa and Indica species. Both species have differences in terms of cannabinoid profile and ultimately effects. Different combinations of both species have now been used to artificially produce hybrid strains that are more unique and well suited to meet most of the needs of cannabis users. Due to their versatility, most cannabis users often prefer to go for hybrid strains and there are quite a number of them available presently.

It should be noted that a major change in trend has been ongoing in the cannabis industry. Unlike before, the majority of cannabis users now want more CBD strains and less euphoric dominant strains. This trend is expected to continue into 2021 as the prominence of CBD strains continues to grow due to their relaxing and medicinal benefits.

Different cannabis strains, when properly used, can help with a good number of ailments and conditions. Early research conducted on CBD already shows positive results on some unique conditions, and with more works of research, a lot more will be understood about its degree of effectiveness.

Examples of the unique conditions these strains can be used for include social anxiety disorder, post-traumatic stress disorder, obsessive-compulsive disorder, and panic disorder. With the cannabis world trending in the direction of CBD, strains with high CBD content are taking center stage.

Australia’s national science agency has been granted a manufacturing licence to develop medicinal cannabis products by the Australian Office of Drug Control.

The Commonwealth Scientific and Industrial Research Organisation (CSIRO) says it will work to bridge the gap between cannabis cultivation and medicine manufacture, developing protocols and the first prototype products before transferring the technology to manufacturers.

“We had been able to do early-stage work with cannabis, but the new licence will enable us to develop cannabis-derived cannabinoid medicines using innovative extraction, refinement and formulation techniques,” said CSIRO Scientist, Adjunct Professor Peter Duggan.

The news was welcomed by ASX-listed Cann Group, which  has worked closely with CSIRO for more than three years.

“With this independent license CSIRO will be able to play a key role in helping establish a vibrant industry in Australia,” said Cann Group CEO Peter Crock.

Rhode Island is looking for an experienced person or a firm to create and run a lottery in May to decide who operates six proposed new medical marijuana dispensaries.

On Friday the state posted online a request for proposals to “design and develop the methodology for the random selection process,” that would be held, in public, around May 14.

“The firm or individual will be primarily responsible for securing all equipment, technology, or other necessary mediums to run the process.”

Lotteries have been used in other jurisdictions around the country to decide who wins the often lucrative licenses, but the practice hasn’t been universally endorsed here.

Several local marijuana business owners have said operating licenses should be based on merit, with those companies with proven track-records better positioned to run new dispensaries than newcomers.

The law also includes several provisions aimed at promoting social equity in the cannabis industry and repairing damage caused by prohibition.

On Monday, New Jersey’s Democratic Governor Phil Murphy signed legislation that legalizes adult-use marijuana possession and licenses retail marijuana sales.

“The enactment of these laws is long overdue,” said NORML State Policies Manager Carly Wolf — whoemphasized that state and local police have made over 6,000 arrests for marijuana-related violations in the months since NewJersey voters overwhelmingly decided at the ballot box. “Now, going forward, tens of thousands of otherwise law-abiding New Jerseyans will no longer be subject to arrest and a criminal record for their personal use of marijuana, and the commercial market will be regulated in a fair and inclusive manner.”

Photo by omersukrugoksu/Getty Images

NORML stated that three bills were signed by the Governor. A21/S21 licenses the commercial production and retail sale of cannabis to adults. Under the new law, adults may legally purchase and possess up to one ounce of cannabis. Retail sales are subject to state sales tax. Seventy percent of the revenue derived from sales taxes on retail marijuana purchases will be directed toward reinvestment in designated, lower-income communities. Sales are expected to begin this summer.

The cannabis community is certainly pleased to see that the state of Virginia has legalized adult-use cannabis, but it will be some time before sales can begin. Still, despite support for the legislation it looked to be a nail-biter to the end. The Virginia House and Senate lawmakers were in agreement on passing the law, but they differed on just exactly what it would look like.

The two sides have been working over the past few weeks to reach a compromise, which was beginning to look less possible. Then on Saturday, it seemed the law just managed to squeak through. Marijuana Moment reported, “The Senate voted 20-19 to approve the conference committee report on its bill as well as the identical version for the House legislation. The House voted to approve the conference report on its bill, 48-43, with two abstentions. When considering the Senate version, the House voted 47-44, with one abstention.”

The next stop for the legislation goes to Democratic Gov. Ralph Northam, who supports legalization. However, it will be some time before Virginians will actually be able to purchase adult-use cannabis in the state.

Sales Begin January 1, 2024

Part of the compromise included a compromise towards having enough time to create the program’s regulations. Marijuana Moment reported that “The Senate has pushed for a reenactment clause to be included which would extend the process into next session, whereas the House side wanted to complete legislative work during the current session, arguing that enough research has already been done to effectively decide the issue. But Senate negotiators won out, meaning that the legislature will revisit cannabis regulations and post-legalization penalty structures next session.

Are These Cannabis Stocks On Your March Watchlist?

On February 23rd the entire stock market was down. This presented a good chance to find top marijuana stocks to buy at lower prices. Moments like this can be a good opportunity for investors as prices start to dip. Now just because you buy the dip does not always mean that a particular cannabis stock will immediately recover. Sometimes it may take a bit to see some momentum pick back up.

The CBD industry has attracted a great deal of attention over the last few years. A combination of high profile cases in the media and an investment in research has led to an increasing number of people showing interest in the potential benefits of CBD.

Research into the varying benefits of CBD has shown that it can be an extremely versatile supplement affecting health in a number of positive ways. A large number of studies have focused on the benefits of using CBD as a general wellness supplement.

There have also been more focused research projects that have found CBD possesses powerful anti-inflammatory capabilities and has led CBD to become a common natural remedy for treating related inflammatory conditions.

The effect of CBD on mental health and, in particular, anxiety and stress is another popular area of research and one that has attracted a great deal of interest. Early studies have yielded positive results, causing a rise in CBD products and PureKana CBD gummies focused on managing mental health.

Research into CBD and mental health

Cultivation, one of humanity’s oldest crafts, is undergoing radical transformation. And it has cannabis grows to thank for it.  

The roots of farming go back more than 12,000 years as hunter-gatherers established agrarian communities to centralize food production, sharing the work and harvest.

Naturally, these early societies recognized that certain crops grew in abundance in certain climates and cultivated those crops that allowed their civilizations to thrive. 

With trade, commodity crops grown in one area became highly prized and profitable elsewhere – from the Far East spice trade to finding fresh papaya in a New York City bodega.  

The cannabis industry can’t follow this simple, ancient calculus. 

Connecticut Governor Ned Lamont would like to see legal cannabis in his state, both because he would like to bring more money into Connecticut, and because he hopes legalization will help end racial disparity in arrests in the state. To make this a reality, he has introduced a bill to the legislature. 

While Lamont realizes that this plan may take some extra convincing, since Republicans are likely to fight back throughout the legislative process, and Democrats would like to see an even more liberal bill, he feels good about being able to come up with a solution. 

“This is the beginning of a discussion, not the end of a discussion,” he said regarding the proposal. “This has been a long time coming. We have been talking about this for ages,” Lamont said. “I think now is the time for legalized adult-use recreational marijuana in a carefully regulated way with an emphasis on equity and justice.”

The bill focuses on decriminalization, regulation, and generating revenue when it comes to the proposed, legal industry. This Friday, the state will hold a public hearing about the proposal. 

If legalization passes, sales could begin in May of 2022. Projections reveal that Connecticut could raise as much as $33.6 million for the 2023 budget, and $97 million by 2026. 

The Idaho Senate has passed a resolution that bans the production, sale, and possession of cannabis in the state. The decision is in sharp contrast to what lawmakers and voters are doing in other states.

If passed by the Idaho House of Representatives by a two-thirds margin, the measure would go in front of voters on the midterm election ballot. If passed by voters, it would effectively prohibit cannabis legalization in the state, even if voters later approved it. 

Interestingly, debate on the bill was something of a throwback to the last century, with a significant portion of it revolving on terms that seemed to address the morality of using cannabis.

Idahoans like cannabis, but politicians want to do “what’s right.”

Part of the debate on the cannabis ban centered on issues of right vs. wrong. One Republican senator choked up during debate over the bill, saying: “Good senators, I beg you: we have to keep this state clean,” according to Boise State Public Radio. 

The Idaho Senate’s decision is particularly interesting when you consider how popular marijuana is to actual Idahoans. They frequently cross the Oregon border to buy marijuana. State officials in both Oregon and Washington have reported that some of the counties with the highest amounts of cannabis sales are along the Oregon border.

The Virginia legislature has passed bills to modify the state’s medical marijuana program to allow for the production and sale of herbal forms of cannabis. The measures, House Bill 2218 and Senate Bill 1333, were approved this week with overwhelming majorities in both the House of Delegates and the Virginia Senate.

The legalization of medical marijuana in Virginia began with a strictly limited 2015 law that allowed for CBD and THC-A oils to be used by patients with severe epilepsy. The regulations have been loosened since, and medical marijuana dispensaries selling products with up to 10 milligrams of THC per dose opened in the state last year.

Under Virginia’s current laws, the state medical marijuana program only allows processed forms of cannabis, such as tinctures, edibles, and oils. Herbal forms of cannabis including smokable marijuana are not permitted. With the new change, regulated medical marijuana producers will be permitted to offer products made from “cannabis oil or botanical cannabis,” according to the text of the legislation.

The medical marijuana industry and advocates lobbied for the addition of herbal forms of cannabis to the roster of legal products as a way to improve affordability for patients. The change is expected to greatly increase the number of patients with physician recommendations for medical cannabis, which now totals about 10,000.

Activists Laud The Change

Jenn Michelle Pedini, the executive director of the Virginia chapter of the National Organization for the Reform of Marijuana Laws (NORML), said in a press release that the change will make patients’ medicine accessible in the form many prefer.

Arizona celebrated its first month of recreational marijuana sales yesterday, and there's much to cheer. More than 100 medical marijuana dispensaries have been cleared to sell recreational marijuana to customers 21 years and older, and business is booming. Drive past a Valley dispensary in the middle of the day, and there's a decent chance you'll still find a line outside the door.

For longtime marijuana shoppers in Arizona — MMJ patients, that is — there's been less to celebrate. Ironically, many of them feel that legalization has made marijuana less accessible for them.

One gripe: those lines.

"I should not see young, able-bodied folks coming in and out of a dispensary while there are folks in wheelchairs and using walkers waiting in line," says James Carter, a medical marijuana patient in Mesa.

Some dispensaries, still adjusting to balancing medical and rec sales, have begun implementing new policies that aim to prioritize patients. Many Harvest locations have a special window for medical patients. Territory Dispensary has implemented a cashless, pre-pay system for online orders called TreezPay that expedites the pick-up process, cutting down the amount of time customers have to spend in the store. Raul Molina, COO of The Mint dispensaries, recently told Fox 10 that their goal is to serve medical patients within 10 minutes and recreational patients within 30 minutes.

The University of Florida Institute of Food and Agricultural Sciences (UF/IFAS) announced its partnership with Roseville Farms to implement an industrial hemp program.

The program, which is led by Brian Pearson, an assistant professor of crop management at the UF/IFAS Mid-Florida Research and Education Center, "provides a science-based evaluation of industrial hemp varieties," the organization states in a news release.

While South Dakota is still stalled when it comes to making legal cannabis a reality within state borders, the state is already working on legislation that allows banks to decide whether or not to do business with the legal cannabis and hemp industry. 

Topical CBD (cannabidiol) products are becoming increasingly popular – but recent testing indicates some who use them may not be getting what they paid for.

CBD topicals are being used for a number of applications including general cosmetics, moisturising, treating skin irritations and to relieve muscle and joint pain. Research indicates cannabidiol may be effective in treating or managing a number of skin problems.

As an active ingredient it’s important that what’s in the product is reflected by what’s on the label.

Leafreport engaged Canalysis Laboratories to test dozens of CBD topicals including creams, balms, serums and toners, and found 31 of the 40 products contained 12% to 99% cannabidiol versus what was on the label either way (less or more). Just 9 of the products had CBD levels within 10% of the label and 11 were off 30% or more from what the label noted. The majority of the products (31 or 77.5%) contained more CBD than advertised.

While more CBD may sound like a good thing, it raises the question – if a company can’t get CBD levels pretty right, what else is happening with the product? Additionally, more CBD than indicated can make it difficult for a user to determine what they actually need.